An Integrative Approach to Neurotoxicology

Toxicologic Pathology

Volumn 28, Issue 1, 2000, Pages 37-42

  Dorman, David C ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); acrylamide; manganese; Neurotoxicology; risk assessment; trimethyltin

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACRYLAMIDE; IVERMECTIN; MANGANESE; TRIMETHYLTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ASTROCYTE; CONFERENCE PAPER; DOSIMETRY; DRUG MECHANISM; HUMAN; HUMAN CELL; NERVE CELL LESION; NEUROTOXICOLOGY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANIMALS; HUMANS; NERVOUS SYSTEM DISEASES; NERVOUS SYSTEM PHYSIOLOGY; NEUROLOGY; NEUROTOXICITY SYNDROMES; TOXICOLOGY;

ANIMALIA;

EID: 0033961087     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800106     Document Type: Article

References (62)

1. Abbott NJ, Revest PA, Romero IA (1992). Astrocyte-endothelial interaction: Physiology and pathology. Neuropathol Appl Neurobiol 18: 424-433.
2. Albee RR, Mattson JL, Yano BL, Chang LW (1987). Neurobehavioral effects of dietary restriction in rats. Neurotoxicol Teratol 9: 203-211.
3. Alessandri B., Fitzgerald RE, Schaeppi U., Krinke GJ, Classen W. (1994). The use of an unbaited tunnel maze in neurotoxicology: I. Trimethyltin-induced brain lesions. Neurotoxicology 15: 349-357.
4. Aschner M. (1999). Manganese homeostasis in the CNS. Environ Res 80: 105-109.
5. Barbeau A. (1984). Manganese and extrapyramidal disorders. A critical review and tribute to Dr. George C. Cotzia. Neurotoxicology 5: 1336.
6. Besser R., Kramer G., Thumler R., Bohl J., Gutmann L., Hopf HC (1987). Acute trimethyltin limbic-cerebellar syndrome. Neurology 37: 94550.
7. Boyes WK, Miller DB (1988). A review of rodent models of manganese neurotoxicity. Neurotoxicology 19: 468 (abstract).
8. Brenneman KA, Cattley RC, Ali SF, Dorman DC (1999). Manganese-induced developmental neurotoxicity in the CD rat: Is oxidative damage a mechanism of action? Neurotoxicology 20: 477-488.
9. Broxup B., Robinson K., Losos G., Beyrouty P. (1989). Correlation between behavioral and pathological changes in the evaluation of neurotoxicity. Toxicol Appl Pharmacol 101: 510-520.
10. Bushnell PJ, Angell KE (1992). Effects of trimethyltin on repeated acquisition (learning) in the radial-arm maze. Neurotoxicology 13: 429-441.
11. Butterworth RF (1993). Portal-systemic encephalopathy: A disorder of neuron-astrocytic metabolic trafficking. Dev Neurosci 15: 313-319.
12. Calleman CJ, Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton KM, Fennell T., Costa LG (1994). Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol Appl Pharmacol 126: 361-371.
13. Calne DB, Chu NS, Huang CC, Lu SS, Olanow W. (1994). Manganism and idiopathic Parkinsonism: Similarities and differences. Neurology 44: 1583-1586.
14. Chang LW (1990). The neurotoxicology and pathology of organo-mercury, organolead, and organotin. J Toxicol Sci 15(suppl 4): 125-151.
15. Cohn J., MacPhail RC (1996). Acute trimethyltin exposure produces nonspecific effects on learning in rats working under a multiple repeated acquisition and performance schedule. Neurotoxicol Teratol 18: 99-111.
16. Di Monte DA, Royland JE, Irwin I., Langston J. (1996). Astrocytes as the site for bioactivation of neurotoxins. Neurotoxicology 17: 697-703.
17. Dobbing J., Sands J. (1971). Vulnerability of developing brain. IX. The effect of nutritional growth retardation on the timing of the brain growth-spurt. Biol Neonate 19: 363-378.
18. Dyer RS, Walsh TJ, Wonderlin WF, Bercegeay M. (1982). The trimethyltin syndrome in rats. Neurobehav Toxicol Teratol 4: 127-133.
19. Earley B., Burke M., Leonard BE (1982). Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochem Int 21: 351-366.
20. Eriksson H., Gillberg PG, Aquilonius SM, Hedstrom KG, Heilbronn E. (1992). Receptor alterations in manganese intoxicated monkeys. Arch Toxicol 66: 359-364.
21. Eriksson H., Tedroff J., Thuomas KA, Aquilonius SM, Hartvig P., Fasth KJ, Bjurling P., Langstrom B., Hedstrom KG, Heilbronn E. (1992). Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 66: 403-407.
22. Evans PH (1993). Free radicals in brain metabolism and pathology. Br Med Bull 49: 577-587.
23. Felipo V., Hermenegildo C., Montoliu C., Llansola M., Minana MD (1998). Neurotoxicity of ammonia and glutamate: Molecular mechanisms and prevention. Neurotoxicology 19: 675-681.
24. Fortemps E., Amand G., Bomboir A., Lauwerys R., Laterre EC (1978). Trimethyltin poisoning. Report of two cases. Int Arch Occup Environ Health 41: 1-6.
25. Gerber GJ, O'Shaughnessy D. (1986). Comparison of the behavioral effects of neurotoxic and systemically toxic agents: How discriminatory are behavioral tests of neurotoxicity? Neurobehav Toxicol Teratol 8: 703-710.
26. Gerlach M., Riederer P., Przuntek H., Youdim MB (1991). MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol 208: 273-286.
27. He FS, Zhang SL, Wang HL, Li G., Zhang ZM, Li FL, Dong XM, Hu FR (1989). Neurological and electroneuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers. Scand J Work Environ Health 15: 125-129.
28. Heiss WD (1981). Cerebral blood flow: Physiology, pathophysiology and pharmacological effects. Adv Otorhinolaryngol 27: 26-39.
29. Hill JM, Switzer RC III (1985). The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11: 595-603.
30. Janzer RC (1993). The blood-brain barrier: Cellular basis. J Inherited Metab Dis 16: 639-647.
31. Johannessen JN (1991). A model of chronic neurotoxicity: Long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons. Neurotoxicology 12: 285-302.
32. Johansson BB (1990). The physiology of the blood-brain barrier. Adv Exp Med Biol 274: 25-39.
33. Juurlink BH, Paterson PG (1998). Review of oxidative stress in brain and spinal cord injury: Suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 21: 309-334.
34. Kastin AJ, Kuzemchak B., Tompkins RG, Schally AV, Miller MC III (1976). Melanin in the rat brain. Brain Res Bull 1: 567-572.
35. Langston JW, Ballard P., Tetrud JW, Irwin I. (1983). Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980.
36. Lankas GR, Cartwright ME, Umbenhauer D. (1997). P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectininduced neurotoxicity. Toxicol Appl Pharmacol 143: 357-365.
37. Lankas GR, Wise LD, Cartwright ME, Pippert T., Umbenhauer DR (1998). Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 12: 457-463.
38. LoPachin RM, Aschner M. (1999). Neuronal-glial interactions as potential targets of neurotoxicant effect. In: Neurotoxicology, Tilson HA and Harry GJ (eds). Taylor and Francis, Philadelphia, Pennsylvania, pp 53-80.
39. Lyden A., Larsson BS, Lindquist NG (1984). Melanin affinity of manganese. Acta Pharmacol Toxicol 55: 133-138.
40. Lynch JJ III, Silveira LC, Perry VH, Merigan WH (1992). Visual effects of damage to P ganglion cells in macaques. Vis Neurosci 8: 575-583.
41. Marsden CD (1969). Brain melanin. In: Pigments in Pathology, Wolman M (ed). Academic Press, New York, pp 395-420.
42. Maurissen JP, Weiss B., Davis HT (1983). Somatosensory thresholds in monkeys exposed to acrylamide. Toxicol Appl Pharmacol 71: 266-279.
43. Merigan WH, Barkdoll E., Maurissen JP (1982). Acrylamide-induced visual impairment in primates. Toxicol Appl Pharmacol 62: 342-345.
44. Moorcraft WH (1981). Heightened arousal in the 2-week-old rat: The importance of starvation. Dev Psychobiol 14: 187-199.
45. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., Osame M. (1999). Manganese intoxication during total parenteral nutrition: Report of two cases and review of the literature. J Neurol Sci 162: 102-105.
46. Nicklas WJ, Saporito M., Basma A., Geller HM, Heikkila RE (1992). Mitochondrial mechanisms of neurotoxicity. Ann NY Acad Sci 648: 28-36.
47. Niittykoski M., Lappalainen R., Jolkkonen J., Haapalinna A., Riekkinen P., Sirvio J. (1998). Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats. Neurosci Biobehav Rev 22: 735-750.
48. Olanow CW, Good PF, Shinotoh H., Hewitt KA, Vingerhoets F., Snow BJ, Beal MF, Calne DB, Perl DP (1996). Manganese intoxication in the rhesus monkey: A clinical, imaging, pathologic, and biochemical study. Neurology 46: 492-498.
49. O'Shaughnessy DJ, Losos GJ (1986). Comparison of central and peripheral nervous system lesions caused by high-dose short-term and low-dose subchronic acrylamide treatment in rats. Toxicol Pathol 14: 389-394.
50. Pardridge WM (1998). CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70: 1781-1792.
51. Riachi NJ, Behmand RA, Harik SI (1991). Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains. Brain Res 555: 19-24.
52. Saita K., Ohi T., Hanaoka Y., Furukawa S., Furukawa Y., Hayashi K., Matsukura S. (1995). Effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental acrylamide-induced neuropathy in rats. Neurotoxicology 16: 403-412.
53. Saunders NR, Habgood MD, Dziegielewska KM (1999). Barrier mechanisms in the brain. II. Immature brain. Clin Exp Pharmacol Physiol 26: 85-91.
54. Sette WF, MacPhail RC (1992). Qualitative and quantitative issues in assessment of neurotoxic effects. In: Neurotoxicology, Tilson HA and Mitchell C (eds). Raven Press Ltd, New York, pp 345-361.
55. Shinotoh H., Snow BJ, Hewitt KA, Pate BD, Doudet D., Nugent R., Perl DP, Olanow W., Calne DB (1995). MRI and PET studies of manganese-intoxicated monkeys. Neurology 45: 1199-1204.
56. Spencer PS, Schaumburg HH (1975). Nervous system degeneration produced by acrylamide monomer. Environ Health Perspect 11: 129-133.
57. Sundstrom E., Samuelsson EB (1997). Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents. Pharmacol Toxicol 81: 226-231.
58. Trevor AJ, Singer TP, Ramsay RR, Castagnoli N. Jr (1987). Processing of MPTP by monoamine oxidases: Implications for molecular toxicology. J Neural Transm 23(suppl): 73-89.
59. van Asperen J., Mayer U., van Tellingen O., Beijnen JH (1997). The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci 86: 881-884.
60. Wild HM, Kulikowski JJ (1984). Neurotoxic effects of acrylamide on rat retinogeniculate fibres. Behav Brain Res 13: 201-207.
61. Zola-Morgan S., Squire LR, Ramus SJ (1994). Severity of memory impairment in monkeys as a function of locus and extent of damage within the medial temporal lobe memory system. Hippocampus 4: 483-495.
62. Zuddas A., Fascetti F., Corsini GU, Piccardi MP (1994). In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: A model of natural resistance to MPTP toxicity. Exp Neurol 127: 54-61.